Tumor therapy in dogs with interleukin-releasing cell lines*

For the treatment of the majority of tumors diseases in dogs, only classical procedures by surgical removal of the tumor, radiation and chemotherapy are available, the development of new and patient-friendly therapy concepts is indispensable. A new therapeutic strategy provides for the use of biologically active canine interleukines ? especially interleukin-2 (cIL-2) and/or interleukin-12 (cIL-12). These canine interleukines are released by transfected BHK-Tet-on cells and transform in coculture natural killer cells (NK cells) isolated from the patient into lymphokine-activated killer cells (LAK cells), which are, transferred back into the patient, highly effective in the therapy of tumors.

Further Information: PDF

TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12

Dr. Peter Stumpf

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

Alle Nachrichten aus der Kategorie: Technology Offerings

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

Grow faster, die sooner: How growth rates influence the fitness of bacteria

“The fitness of bacteria is more complex than expected,” explains Ulrich Gerland, professor for the theory of complex biosystems at the Technical University of…

Spintronics: Researchers show how to make non-magnetic materials magnetic

In solid-state physics, oxide layers only a few nanometres thick are known to form a so-called two-dimensional electron gas. These thin layers, separated from…

Caterpillars of the wax moth love eating plastic: Fraunhofer LBF investigates degradation process

Within the Framework of a research project on the chemical imaging analysis of plastic digestion in caterpillars (RauPE), a team from Fraunhofer LBF used…